all only 30% of patients in need of an allogeneic transplantation have a suitable family donor. 1 The search for an unrelated donor is expensive, time-consuming and transplanOne of the main limiting factors for increased use of human umbilical cord blood (UCB) in adult allogeneic tation is associated with an increased risk of graft rejection, GVHD and opportunistic infections. 2 UCB as an alternative transplantation is the small number of progenitor cells that can be collected and infused. Ex vivo expansion of source of hematopoietic stem cells can be easily collected, cryopreserved and stored. Of great interest is the reported UCB might help to overcome this limitation. Whether an expansion of UCB cells will also lead to co-expansion low rate of acute grade III-IV GVHD after UCB transplantation. [3] [4] [5] Moreover, chronic GVHD seems to be uncomof contaminating maternal cells, and thus may alter graft characteristics and lead to an increased incidence mon. 5, 6 One of the main limiting factors for UCB transplantation, however, is the limited volume of UCB that can of GVHD, has not been looked at so far. We initiated cultures with UCB mononuclear cells (MNC) in a stanbe collected and thus the relatively small number of total nucleated cells and hematopoietic progenitor cells that can dard medium containing stem cell factor (SCF), flt-3L, Il-3, IL-6, EPO and G-CSF. To address the question of be infused. 5 Therefore, most experience with UCB transplantation has been obtained in the pediatric setting. To contaminating maternal cells we performed interphase FISH analysis of the X and Y chromosome simulincrease the number of hematopoietic progenitor cells and to make UCB transplantation suitable for the adult patient, taneously. Male (XY) cord blood samples were investigated for maternal (XX) cells at day 0 and at several ex vivo expansion of UCB is gaining more and more attention. time points during culture. We could not detect maternal cells in any of the nine samples studied when
Cell preparation and cell cultures
formamide/2 × SSC. Immediately afterwards slides were dehydrated in ethanol (70%, 96%, 100%, 1 min each) and Mononuclear cells (MNC) were isolated from maternal and allowed to air-dry. The denatured probe (5 min at 75°C) cord blood on a density gradient (Lymphoprep, density was then placed onto the preheated slides, a coverslip was 1.077 g/ml; Nycomed, Oslo, Norway) according to standard added and sealed with rubber cement. After overnight procedures. Cultures were started in 24-well plates (Nunc, hybridization in a moist chamber at 37°C slides were Naperville, IL, USA). The unseparated MNC fraction was washed in 0.4 × SSC at 75°C for 2 min and in seeded at a concentration of 1 × 10 6 cells/ml in 1 ml Isco-2 × SSC/0.1% NP-40 (Vysis) for 1 min at room temperave's modified Dulbeccos's medium (IMDM; Gibco, Paisture. Slides were then allowed to air-dry in darkness. Nuclei ley, UK) containing 130 ng/ml SCF (Amgen, Munich, were counterstained with DAPI II (Vysis). A control slide Germany), 8 ng/ml IL-3 (Behring, Marburg, Germany), was included in each experiment. Hybridization efficiency 20 ng/ml IL-6 (Genetics Institute, Cambridge, MA, USA), was у98%. Nuclei containing both a green and a red signal 13 ng/ml G-CSF (Amgen), 0.4 U Epo (Cilag, Sulzbach, were scored as male; only cells exhibiting no green and Germany) and 50 ng/ml flt-3L (1CC, Ismaning, Germany) double red signals were scored as maternal cells. At least (referred to as the culture medium). For controlled contami-500 cells were counted. To validate the specificity and sennation of male umbilical cord blood samples, maternal sitivity of our detection system, we examined control cell MNC were added to the umbilical MNC at a concentration preparations with 100% male and 100% female cells. No of either 5 or 15%. No reseeding or refeeding of either cells of the opposite sex could be identified in at least 1000 cytokines or medium was performed within the culture nuclei scored. Control cell preparations of female MNC period.
artificially spiked into male MNC were performed at con-CD34
+ cell selection was performed with the Miltenyi centrations of 50% down to 0.2% female cells. These MiniMACS column according to the manufacturer's mandilution experiments revealed that the adequate number of ual (Miltenyi Biotec, Bergisch-Gladbach, Germany (20-50 cells) mal controls (data not shown). Maternal MNC were then artificially spiked at concentrations of 5% and 15% into and colonies (Ͼ50 cells, scored as CFU-GEMM, CFU-GM, BFU-E and CFU-E) were counted.
1 × 10 6 male cord blood nucleated cells. FISH analysis was performed on days 0 and 14. In all cases the percentage of maternal cells declined during culture period. In three experiments with 5% calculated contamination maternal Results cell content decreased from a mean of 5.1% detected maternal cells on day 0 to 1.7% on day 14 ( Table 1 , Nine male cord blood samples were investigated for maternal cells at day 0. MNC isolation was performed and Figure 2 ). In two experiments with calculated 15% contamination the content of maternal cells declined from a the FISH technology was applied to detect maternal cells. In all samples we could find male nucleated cells only detected 12.2% maternal cells on day 0 to 3.7% on day 7, in two other experiments from 15% on day 0 to 6% on day ( Figure 1 ). The mononuclear cell fraction was then seeded at a cell concentration of 1 × 10 6 cells/ml in standard media 14 ( Table 2 ). An example of a contaminating maternal cell after day 14 of culture is shown in Figure 3 . supplemented with a cytokine cocktail optimized for the expansion of hematopoietic progenitor cells. As has been
Because of the limited expansion capacity of unseparated MNC most groups perform CD34
+ selection before initiatreported by others, 17 the proliferative potential of the mononuclear cell fraction is limited under standard culture coning cultures. We used an immunomagnetic device for CD34 + selection (see Materials and methods). UCB ditions. At day 7 we could see a mean 1.6-fold (range: 0.6-2.5 fold, s.e.m. ± 0.5, n = 19), at day 14 a mean 2.33-fold nucleated cells were spiked with 5% (n = 2) or 2.5% (n = 1) maternal cells before selection was started. CD34 + purity (range: 0.8-5.2-fold, s.e.m. ± 0.77, n = 19) total cell number proliferation as compared to the initial cell number at after selection was 55.2% (range: 36-67%), CD34 + selection itself proved to decrease maternal cell content, as after day 0. Interestingly, the mean percentage of CD34 + cells increased from 0.94% (range: 0.29-4.2%, s.e.m. ± 0.67%, selection only between 1.27% and 2.04% maternal cells could be found, which translates into a mean logarithmic n = 19) at day 0 to 5.77% (range: 1.0-14.4%, s.e.m. ± 3.3%, n = 19) at day 7 and 3.06% (range: 0.08-20.54%, reduction of maternal cells of 0.38 (Table 3) . Cell number proliferation was 7.3-fold (mean) at day 7 s.e.m. ± 3.49%, n = 19) at day 14.
Cells from one well each were harvested at days 7 and (range, 3.1-fold-14-fold) without reseeding or refeeding with cytokines. Percent maternal cell content decreased in 14 and FISH analysis was performed again. Neither at day 7 nor at day 14 could we find maternal cells in the examall samples during culture from a mean of 1.64% (range, ined cord blood samples. Thus, culturing of human UCB did not expand previously undetectable maternal cells into a range that could be detected with FISH technology. Figure 1 Fluorescence in situ hybridization of male cord blood MNC on day 0. Male cord blood MNC were obtained as described in the Cord blood MNC were contaminated with 5% maternal MNC at day 0. Cultures were initiated as described in the Materials and methods: At day Materials and methods. FISH was performed with the green signal identifying the Y and the red signal identifying the X chromosome. Only cells 14, wells were harvested, cell counts performed and maternal cell content determined with FISH. Looking at mean values, cord blood MNC showed containing both a green and a red signal could be detected on day 0, thus we could not show maternal cell contamination of UCB mononuclear an increase in overall cell numbers, whereas maternal cell content declined during culture period. cells. Magnification: 63-fold.
itself, as there was no consistent difference in absolute cell numbers between the artificially contaminated and uncontaminated cord blood cells during culture (data not shown). There was, however, a trend towards a somewhat less pronounced increase in CD34 antigen expression on day 7 observed in the UCB cells spiked with maternal cells. The mean percentage of CD34 + cells on day 0 in this set of experiments (n = 3) was 0.8% (range, 0.31-1.58%). On day 7 the UCB mononuclear cell fraction seeded without maternal cells showed a mean of 8.4% (range, 5.3-10.2%, s.e.m. ± 1.54%) cells with CD34 + expression, whereas the UCB cells contaminated on day 0 with 5% or 15% maternal cells showed a mean of 6% (range, 4.8-7.5%, s.e.m. ± 0.8%) or 5.2% (range, 1.6-7.24%, s.e.m. ± 1.8%) CD34
+ cells on day 7, respectively ( Figure 5 ). On day 14, this trend in CD34 expression could no longer be observed (data not shown).
There was no difference between colony assays started on day 0 with UCB contaminated with 5% or 15% maternal cells and uncontaminated UCB, which again shows that impaired CD34 expression of the contaminated samples vs uncontaminated UCB (see Figure 5) . Also, no difference in colony formation could be observed between the spiked and unspiked samples on day 14.
Discussion
There is concern about maternal cells contaminating human UCB. This could lead to vertical transfer of infectious agents. Furthermore, the transplantation of UCB containing HLA disparate maternal cells may cause GVH reactions. Therefore, several groups looked at the content of maternal cells in UCB collections. An overview of the published results is given in Table 4 . The availability of recently developed highly sensitive PCR methods shows that a COLOUR ARTWORK ID ONLY higher proportion of cord blood samples contains maternal around 0.1% (Table 4 ). In the allogeneic BMT or PBPCT setting a dose of less than 1-2 × 10 5 donor T cells/kg recipient BW appears to 1.27-2.04%) at day 0 after CD34 + selection to a mean of 0.41% (0.17-0.54%) at day 7 (Table 3, Figure 4) . be below the assumed threshold for clonable T cells.
18
Thus, the incidence of GVHD after infusion of a T cellTo see whether contaminating maternal cells alter colony growth and expansion characteristics of UCB, we looked depleted marrow with less than 1 × 10 5 donor T cells/kg recipient BW is decreased. 18 With an average of 10 × 10 8 at cultures of unmanipulated male cord blood MNC negative for maternal cells and cord blood MNC artificially mononuclear cells per cord blood collection, 19 an estimated amount of less than 1 × 10 6 maternal mononuclear cells will spiked with 5% or 15% maternal MNC. On days 0, 7 and 14, absolute cell numbers and CD34 + cell content were be collected if assuming a maternal cell content of 0.1%. In consequence, only heavily contaminated UCB collecexamined, as well as colony assays started.
Maternal cells did not influence UCB cell proliferation tions will contain more than 1 × 10 5 maternal T cells/kg Cord blood MNC were contaminated with 15% maternal MNC. Cultures were initiated as described in the Materials and methods. At days 7 (n = 2) or 14 (n = 2) wells were harvested, cell counts performed and maternal cell content determined with FISH. Except for sample 3 cord blood cells showed an increase in overall cell numbers, whereas maternal cell content declined in all four samples during culture period.
recipient BW. The caution concerning transfer of maternal Abecasis et al 20 report an UCB transplantation with about 25% maternal cells in the graft with 100% donor chimerism cells, however, seems to be justified: maternal cells need only share one haplotype with the cord blood cells and and only grade I acute GVHD. On the other hand, GVHD after long-term engraftment of maternal cells in infants with could show substantial HLA disparity with the cord blood recipient. Therefore, the threshold dose for maternal T cells SCID is a rare, but a well recognized phenomenon. 21, 22 Taken together, the significance of maternal cell content in mediating GVHD might be lower than the above-mentioned threshold for donor T cells mediating GVHD in the conventhe transplantation of unexpanded UCB still awaits further evaluation especially with regard to the question whether tional allogeneic setting. Furthermore, maternal cell content could be relevant to the issue of graft rejection. However, the occurrence of severe GVHD in UCB transplantation correlates with the content of maternal cells in the graft. no correlation between maternal cell content in the graft and incidence or severity of GVHD or graft rejecOne of the main limiting factors for UCB transplantation in adults is the small number of total nucleated cells as well tion/engraftment failure has been reported as yet. In fact, Cord blood MNC were contaminated with 5% (n = 2) or 2.5% (n = 1) maternal MNC. CD34 + cell selection was performed (see Materials and methods), mean purity was 55.2%. Cultures were initiated with 2 × 10 5 cells, maternal cell content was examined with FISH on days 0 and 7. Cord blood cells showed a marked increase in overall cell numbers, whereas the percentage of maternal cells in culture declined to the detection limit of our method during culture. Therefore the observed slight increase in overall maternal cells is probably related to methodological limitations.
as hematopoietic progenitor cells in UCB compared to BMT or PBPCT collections. 5 Consequently, much effort concentrated on the in vitro expansion of UCB progenitor cells. An increase in progenitor cells during culture could make cord blood suitable for adult allogeneic transplantation by reducing time to neutrophil recovery and time to platelet transfusion independence, as these parameters depend on the number of progenitor cells transfused per kilogram recipient body weight. 23, 24 However, ex vivo expansion of UCB may be accompanied by co-expansion of contaminating maternal cells.
We examined the maternal cell content of nine UCB samples before cultures were initiated. We could not detect any maternal cells on day 0. Mixing experiments with controlled contamination of female MNC into male MNC revealed a sensitivity of our FISH methodology of 0.5%. Therefore maternal cells, if present at all, seem to reconstitute less than 0.5% of UCB cells. These findings are in accordance with published data (Table 4) . During culture periods all UCB samples screened negative for maternal before initiating cultures. In our hands, CD34 + cell purification with an immunomagnetic device reduced maternal cell content by a logarithmic mean of 0.38. This does not seem to be very much compared to a tumor cell reduction of у2 log steps, which can be obtained by immunomagnetic CD34 + selection. 25, 26 The reason for this is the poor CD34 + cell purity we could achieve (mean 55.2%). Better CD34 + purities after selection should lead to an improved maternal cell reduction. However, maternal cell content of the purified CD34 + cell fraction further declined during culture. Therefore, it can be said that the medium and cytokine cocktail used expands UCB cells, and any possible contamination of UCB with maternal cells will not be increased under these culturing conditions. The main reason for this selective expansion of cord blood cells is probably the cytokine cocktail itself, which is optimized for culturing of hematopoietic progenitor cells and does not contain factors like IL-2, that could support growth of maternal T cells. As maternal MNC do not contain hematopoietic stem cells in a significant number, growth of cells with maternal origin is not supported. However, other explanations like the occurrence of immune-mediated clearance of maternal cells by cord blood lymphocytes or natural killer cells cannot be excluded.
There was no difference in absolute cell number proliferation between the artificially spiked MNC fraction and the proliferation of UCB mononuclear cells does not seem to 
